Celltrion finds distributor of ‘Truxima & Herzuma’ in North America

Published: 2016-10-10 11:10:14

Updated: 2016-10-10 11:10:14

A U.S. distributor for the Celltrion’s second and third biosimilars was decided.

A company taking charge in Celltrion products’ overseas marketing, Celltrion Healthcare announced on the 6th it chose a global pharmaceutical company headquartered in Israel, ‘Teva,’ as an exclusive distributor of ‘Truxima(project name: CT-P10)’ and ‘Herzuma(project name: CT-P6)’ in the U.S. and Canada.

‘Truxima...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.